VP & Head of Gene Therapy at Generation Bio
Serving as vice president of biology at Wave Life Sciences from 2016 through 2019, Zhong supported the development of an oligotherapeutics pipeline for central nervous system, ophthalmology, hepatic/metabolic and muscle diseases. Previously, at Vertex Pharmaceuticals, he established a research site in Shanghai before moving to Boston in 2015 to oversee external research and innovation projects. From 2008 to 2013, as part of GSK’s leadership team for neuroscience research, Zhong established both platform functions and a stem cell discovery performance unit. He also led the GSK neuroinflammation R&D team, which delivered clinical candidates for several multiple sclerosis clinical studies. Zhong started his career at J&J, developing cell assay technologies, as well as leading operations and research for the startup Cell & Molecular Technologies Inc through its acquisition and integration by Invitrogen (now Thermo Fisher Scientific). Zhong received his doctorate from The Rockefeller University.
VP & Head of Gene Therapy